Results 1 to 10 of about 82,726 (255)

Complement C3 recognition by C3 convertases. [PDF]

open access: yesSci Adv
Abstract The complement system plays a fundamental role in human immunity, and its dysregulation is implicated in numerous diseases. Activation of the complement occurs through three main pathways: classical, lectin, and alternative; which converge at the central component, C3.
Jia C, Yang X, Zhao MH, Tan Y, Xiao J.
europepmc   +3 more sources

Association between complement C3 and the prevalence of metabolic-associated fatty liver disease in a Chinese population: a cross-sectional study

open access: yesBMJ Open, 2021
Objectives Recently studies demonstrated that adipose tissue can produce and release complement C3 and serum complement C3 levels were associated with diabetes mellitus, metabolic syndrome and non-alcoholic fatty liver disease (NAFLD).
Wei-Lin Wang, Ying Zhao, Limin Feng
doaj   +1 more source

Development of a C3 humanized rat as a new model for evaluating novel C3 inhibitors

open access: yesJournal of Innate Immunity, 2023
Introduction: C3 is central for all complement activation pathways, thus an attractive therapeutic target. Many C3-targeted agents are under extensive development with one already approved for clinical use.
Jin Chen   +6 more
doaj   +1 more source

SERUM C3 AND SERUM C4 COMPLEMENT IN PATIENTS WITH BURN TRAUMA AND CORRELATION WITH BURN INJURY SEVERITY

open access: yesSanamed, 2022
Introduction: Burns, depending on the degree of severity, induce a significant pathophysiological response in the body. The complement system participates in the body's defenses as well as in immune responses after burn-induced trauma. Objectives: The
Arslanagic Selma, Karamehic Jasenko
doaj   +1 more source

A novel approach to immunoapheresis of C3a/C3 and proteomic identification of associates [PDF]

open access: yesPeerJ, 2019
Background Complement factor C3 represents the central component of the complement cascade and its activation split product C3a plays an important role in inflammation and disease. Many human disorders are linked to dysregulation of the complement system
Wolfgang Winnicki   +8 more
doaj   +2 more sources

Associations Between Genotype and Peripheral Complement Proteins in First-Episode Psychosis: Evidences From C3 and C4

open access: yesFrontiers in Genetics, 2021
Schizophrenia is a common neuropsychiatric disorder with complex pathophysiology. Recent reports suggested that complement system alterations contributed to pathological synapse elimination that was associated with psychiatric symptoms in schizophrenia ...
Yu Chen   +11 more
doaj   +1 more source

Microarray-based analysis of renal complement components reveals a therapeutic target for lupus nephritis

open access: yesArthritis Research & Therapy, 2021
Background Screening abnormal pathways and complement components in the kidneys of patients with lupus nephritis (LN) and NZB/W mice may help to identify complement-related therapeutic targets for LN.
Tao Liu   +6 more
doaj   +1 more source

Diverse Clinical Presentations of C3 Dominant Glomerulonephritis

open access: yesFrontiers in Medicine, 2020
C3 dominant immunofluorescence staining is present in a subset of patients with idiopathic immune complex membranoproliferative glomerulonephritis (iMPGN).
Ramy M. Hanna   +13 more
doaj   +1 more source

C3‐dependent effector functions of complement

open access: yesImmunological Reviews, 2022
SummaryC3 is the central effector molecule of the complement system, mediating its multiple functions through different binding sites and their corresponding receptors. We will introduce the C3 forms (native C3, C3 [H2O], and intracellular C3), the C3 fragments C3a, C3b, iC3b, and C3dg/C3d, and the C3 expression sites.
Alessandra Zarantonello   +3 more
openaire   +2 more sources

Complement component 3 as biomarker of disease activity and cardiometabolic risk factor in rheumatoid arthritis and spondyloarthritis

open access: yesTherapeutic Advances in Chronic Disease, 2020
Objective: To analyze the relationship between complement component 3 (C3) and the prevalence of cardiometabolic risk factors and disease activity in the rheumatic diseases having the highest rates of cardiovascular morbidity and mortality: rheumatoid ...
Iván Arias de la Rosa   +17 more
doaj   +1 more source

Home - About - Disclaimer - Privacy